February 3rd 2023
Expert perspectives from Amod Sarnaik, MD, and Krishna Komanduri, MD, on the evolving role of tumor-infiltrating lymphocyte therapy in solid tumors, following the Society for Immunotherapy of Cancer (SITC) 2022 meeting.
January 27th 2023
Experts review key updates in LBCL management from the ASH 2022 annual meeting.
